The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor

被引:156
作者
Oberst, MD [1 ]
Williams, CA [1 ]
Dickson, RB [1 ]
Johnson, MD [1 ]
Lin, CY [1 ]
机构
[1] Georgetown Univ, Med Ctr, Lombardi Canc Ctr, Dept Oncol, Washington, DC 20057 USA
关键词
D O I
10.1074/jbc.M304282200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The activation of matriptase requires proteolytic cleavage at a canonical activation motif that converts the enzyme from a one-chain zymogen to an active, two-chain protease. In this study, matriptase bearing a mutation in its catalytic triad was unable to undergo this activational cleavage, suggesting that the activating cleavage occurs via a transactivation mechanism where interaction between matriptase zymogen molecules leads to activation of the protease. Using additional point and deletion mutants, we showed that activation of matriptase requires proteolytic processing at Gly-149 in the SEA domain of the protease, glycosylation of the first CUB domain and the serine protease domain, and intact low density lipoprotein receptor class A domains. Its cognate inhibitor, hepatocyte growth factor activator inhibitor-1, may also participate in the activation of matriptase, based on the observation that matriptase activation did not occur when the protease was co-expressed with hepatocyte growth factor activator inhibitor-1 mutated in its low density lipoprotein receptor class A domain. These results suggest that besides matriptase catalytic activity, matriptase activation requires post-translational modification of the protease, intact noncatalytic domains, and its cognate inhibitor.
引用
收藏
页码:26773 / 26779
页数:7
相关论文
共 31 条
[1]   The plasminogen activation system in tumor growth, invasion, and metastasis [J].
Andreasen, PA ;
Egelund, R ;
Petersen, HH .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (01) :25-40
[2]   Sphingosine 1-phosphate, present in serum-derived lipoproteins, activates matriptase [J].
Benaud, C ;
Oberst, M ;
Hobson, JP ;
Spiegel, S ;
Dickson, RB ;
Lin, CY .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (12) :10539-10546
[3]   Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor [J].
Benaud, C ;
Dickson, RB ;
Lin, CY .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (05) :1439-1447
[4]   Deregulated activation of matriptase in breast cancer cells [J].
Benaud, CM ;
Oberst, M ;
Dickson, RB ;
Lin, CY .
CLINICAL & EXPERIMENTAL METASTASIS, 2002, 19 (07) :639-649
[5]   TRANSITION OF BOVINE TRYPSINOGEN TO A TRYPSIN-LIKE STATE UPON STRONG LIGAND-BINDING - REFINED CRYSTAL-STRUCTURES OF BOVINE TRYPSINOGEN-PANCREATIC TRYPSIN-INHIBITOR COMPLEX AND OF ITS TERNARY COMPLEX WITH ILE-VAL AT 1.9 A RESOLUTION [J].
BODE, W ;
SCHWAGER, P ;
HUBER, R .
JOURNAL OF MOLECULAR BIOLOGY, 1978, 118 (01) :99-112
[6]   LDL-receptor structure - Calcium cages, acid baths and recycling receptors [J].
Brown, MS ;
Herz, J ;
Goldstein, JL .
NATURE, 1997, 388 (6643) :629-630
[7]   Scatter factors and invasive growth [J].
Comoglio, PM ;
Boccaccio, C .
SEMINARS IN CANCER BIOLOGY, 2001, 11 (02) :153-165
[8]  
ESSER V, 1988, J BIOL CHEM, V263, P13282
[9]   Molecular basis of familial hypercholesterolaemia from structure of LDL receptor module [J].
Fass, D ;
Blacklow, S ;
Kim, PS ;
Berger, JM .
NATURE, 1997, 388 (6643) :691-693
[10]   Type II transmembrane serine proteases - Insights into an emerging class of cell surface proteolytic enzymes [J].
Hooper, JD ;
Clements, JA ;
Quigley, JP ;
Antalis, TM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (02) :857-860